Ledger.Open graph →

SEC Form D · filed January 28, 2013

Reven Pharmaceuticals, Inc

Offering

$1.0M

Sold

—

Exemption

—

Industry

Pharmaceuticals

Location

SARASOTA, FL

Type

—

People & firms on this filing (3)

Edward M. Hundert · New York, NYExec · Director Jeffrey R. Brown · New York, NYExec · Director Teresa K. Hassara · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗